Multiple Myeloma and Plasma Cell Neoplasm
Showing 26 - 50 of 286
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +11 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 29, 2020
Multiple Myeloma and Plasma Cell Tumor Trial in Philadelphia (bortezomib, hydroxychloroquine)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Feb 5, 2020
Multiple Myeloma and Plasma Cell Tumor Trial in Rochester (dexamethasone, lenalidomide)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
-
Rochester, MinnesotaMayo Clinic
Jan 9, 2020
Breast Cancer, Chronic Myeloproliferative Disorders, Colorectal Cancer Trial in Pittsburgh, Madison (doxorubicin HCl, motexafin
Completed
- Breast Cancer
- +11 more
- doxorubicin hydrochloride
- motexafin gadolinium
-
Pittsburgh, Pennsylvania
- +1 more
Dec 12, 2019
GVHD, Leukemia, Lymphoma Trial in Buffalo (biological, drug, procedure, radiation)
Completed
- Graft Versus Host Disease
- +4 more
- anti-thymocyte globulin
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Nov 25, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)
Withdrawn
- Leukemia
- +4 more
- alemtuzumab
- +6 more
-
La Jolla, California
- +23 more
Nov 25, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure)
Completed
- Leukemia
- +3 more
- daclizumab
- +4 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 31, 2019
Infection, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore, Philadelphia (biological, drug, procedure)
Completed
- Infection
- Multiple Myeloma and Plasma Cell Neoplasm
- filgrastim
- +8 more
-
Baltimore, Maryland
- +1 more
Oct 31, 2019
Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (carmustine, cisplatin, cyclophosphamide)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- carmustine
- +9 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019
Anemia, GVHD, Leukemia Trial in Baltimore (biological, drug, procedure, radiation)
Completed
- Anemia
- +5 more
- anti-thymocyte globulin
- +6 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure, radiation)
Completed
- Leukemia
- +3 more
- anti-thymocyte globulin
- +5 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019
Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (carmustine, cisplatin, cyclophosphamide)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- carmustine
- +7 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (filgrastim, therapeutic allogeneic lymphocytes,
Completed
- Leukemia
- +3 more
- filgrastim
- +3 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019
Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore, New York (oblimersen sodium, dexamethasone, thalidomide)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- oblimersen sodium
- +2 more
-
Baltimore, Maryland
- +1 more
Oct 15, 2019
Multiple Myeloma and Plasma Cell Tumor Trial in Scottsdale, Jacksonville, Rochester (lenalidomide, melphalan, prednisone)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- lenalidomide
- +2 more
-
Scottsdale, Arizona
- +2 more
Sep 18, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)
Completed
- Leukemia
- +4 more
- therapeutic allogeneic lymphocytes
- +6 more
-
Denver, Colorado
- +13 more
Sep 13, 2019
Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Iowa City, Rochester (RAD001, Sorafenib)
Completed
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
-
Iowa City, Iowa
- +1 more
Aug 9, 2019
Multiple Myeloma and Plasma Cell Tumor Trial in Rochester (dexamethasone, sorafenib tosylate, Lenalidomide)
Terminated
- Multiple Myeloma and Plasma Cell Neoplasm
- dexamethasone
- +2 more
-
Rochester, MinnesotaMayo Clinic
Aug 12, 2019
Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Warsaw (autologous lymphoma cell lysate-pulsed autologous dendritic
Completed
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine
- +2 more
-
Warsaw, PolandMaria Sklodowska-Curie Memorial Cancer Center and Institute of O
Aug 14, 2019
Multiple Myeloma and Plasma Cell Tumor Trial in Phoenix, Duarte (biological, drug, procedure)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- filgrastim
- +7 more
-
Phoenix, Arizona
- +1 more
Jun 24, 2019
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Detroit (biological, drug, other, procedure)
Terminated
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +7 more
-
Detroit, MichiganKarmanos Cancer Institute
Mar 13, 2019
Multiple Myeloma and Plasma Cell Tumor Trial in Boston, Milwaukee (therapeutic allogeneic lymphocytes)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- therapeutic allogeneic lymphocytes
-
Boston, Massachusetts
- +1 more
Dec 30, 2018
Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- sargramostim
- +5 more
-
Jacksonville, Florida
- +11 more
Dec 30, 2018
Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (MILs, Melphalan, PCV13)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- MILs
- +2 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 29, 2018